{"DataElement":{"publicId":"3287797","version":"1","preferredName":"Carboplatin Agent Administered Type","preferredDefinition":"a subdivision related to administration of carboplatin (an anticancer drug that belongs to the family of drugs called platinum compounds).","longName":"3287793v1.0:3287794v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3287793","version":"1","preferredName":"Carboplatin Agent Administered","preferredDefinition":"information related to administration of carboplatin (an anticancer drug that belongs to the family of drugs called platinum compounds).","longName":"2241605v1.0:2233610v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2241605","version":"1","preferredName":"Carboplatin Agent","preferredDefinition":"A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04):An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1282:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carboplatin","conceptCode":"C1282","definition":"A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-222A-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE1AFBC1-CE40-4A0C-E040-BB89AD434199","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3287794","version":"1","preferredName":"Carboplatin Agent Administered Type","preferredDefinition":"a subdivision of being given carboplatin.","longName":"3287794v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"In place of Cisplatin, due to development of specific intolerable Cisplatin-associated toxicities","valueDescription":"In place of Cisplatin, due to development of specific intolerable Cisplatin-associated toxicities","ValueMeaning":{"publicId":"3287795","version":"1","preferredName":"In place of Cisplatin, due to development of specific intolerable Cisplatin-associated toxicities","longName":"3287795","preferredDefinition":"In place of Cisplatin, due to development of specific intolerable Cisplatin-associated toxicities","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE1BD3DE-4E70-C692-E040-BB89AD434047","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE1BD3DE-4E89-C692-E040-BB89AD434047","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"As part of original chemotherapy selected prior to registration","valueDescription":"As part of original chemotherapy selected prior to registration","ValueMeaning":{"publicId":"3287796","version":"1","preferredName":"As part of original chemotherapy selected prior to registration","longName":"3287796","preferredDefinition":"As part of original chemotherapy selected prior to registration","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE1BD3DE-4E93-C692-E040-BB89AD434047","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE1BD3DE-4EAC-C692-E040-BB89AD434047","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE1BD3DE-4E5A-C692-E040-BB89AD434047","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"ALAIS","dateModified":"2011-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Carboplatin was administered","type":"Preferred Question Text","description":"Carboplatin was administered","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AE1AFBC1-CE55-4A0C-E040-BB89AD434199","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-09-29","modifiedBy":"ALAIS","dateModified":"2011-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}